Market Tracker

03/04 5:16pm ET

Novo Nordisk A/S (NYSE:NVO)

47.05
Delayed Data
As of 4:04pm ET
 -0.17 / -0.36%
Today’s Change
41.72
Today|||52-Week Range
49.11
+11.18%
Year-to-Date

Today’s Trading

Previous close47.22
Today’s open46.82
Day’s range46.44 - 47.10
Volume783,864
Average volume (3 months)1,352,035
Market cap$97.4B
Dividend yield1.62%
Data as of 4:04pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+5.60%
P/E ratio4.7
Price/Sales7.05
Price/Book18.82

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.65+1.09%
CELGCelgene+1.10+0.93%
BMYBristol-Myers Squibb+3.75+6.06%
AZNAstraZeneca-0.49-0.72%
Data as of 4:01pm ET, 03/04/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.47
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts